Medicine
Norgesic 385 mg/30 mg/25 mg tablet
Norgesic 385 mg/30 mg/25 mg tablet is a prescription medicine containing Aspirin, Caffeine and Orphenadrine for oral use, marketed by Galt Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store below 30°C (86°F).
Key facts
- Active ingredient (INN)
- Aspirin, Caffeine and Orphenadrine
- Brand
- Norgesic
- Strength
- 385 mg/30 mg/25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets
- Marketing authorisation holder
- Galt Pharmaceuticals
- Manufacturer
- Galt Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store below 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 May 2022
- Identifiers
- RxCUI 994528, 994530DailyMed set ID be2761bc-e537-4039-846a-2ffa3d8b2afcNDC 61825-305Application ANDA075141
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet in 1 bottle, plastic | 61825-305-60 | Galt Pharmaceuticals | 16 May 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 4 March 1964 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Aspirin, Caffeine and Orphenadrine 385 mg/30 mg/25 mg tablet.
Other strengths and forms of Aspirin, Caffeine and Orphenadrine
Clinical summary
Aspirin, Caffeine and Orphenadrine is a fixed-dose combination of a central nervous system stimulant, a methylxanthine and a muscle relaxant indicated to moderate pain of acute musculoskeletal disorders. MedsAcross supplies Aspirin, Caffeine and Orphenadrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Aspirin, Caffeine and OrphenadrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Norgesic prescribing information (Galt Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Norgesic 385 mg/30 mg/25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.